4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001209191-20-063277
Executive Vice President acquired 3,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Holsinger Leslie Executive Vice President | 2020-12-10 | Option exercise | +3,500 | $0.27 | $945 | 3,500 | D |
| Derivatives | |||||||
| Holsinger Leslie Executive Vice President | 2020-12-10 | Option exercise · Stock Option (Right to Buy) | −3,500 | 106,794 | D | ||
Loading xslF345X03/doc4.xml…